Application 079153
- Type
- ANDA
- Sponsor
- TORRENT PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 25MG | No | No |
| 002 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 50MG | No | No |
| 003 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 100MG | No | No |
| 004 | TOPIRAMATE | TOPIRAMATE | TABLET;ORAL | 200MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A079153-001 | TOPIRAMATE | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | ||
| A079153-002 | TOPIRAMATE | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | ||
| A079153-003 | TOPIRAMATE | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | ||
| A079153-004 | TOPIRAMATE | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 84e616aacf4f… | ||
| 2026-09-14 22:38:34 | 2026-08 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A079153-001 | TOPIRAMATE | 25MG | TABLET / ORAL | 2009-03-27 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A079153-002 | TOPIRAMATE | 50MG | TABLET / ORAL | 2009-03-27 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A079153-003 | TOPIRAMATE | 100MG | TABLET / ORAL | 2009-03-27 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A079153-004 | TOPIRAMATE | 200MG | TABLET / ORAL | 2009-03-27 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A079153-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A079153-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A079153-003 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A079153-004 | AB | 1 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | A079153-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A079153-002 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A079153-003 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A079153-004 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A079153-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A079153-002 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A079153-003 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A079153-004 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A079153-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A079153-002 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A079153-003 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A079153-004 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A079153-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A079153-002 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A079153-003 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A079153-004 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A079153-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A079153-002 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A079153-003 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A079153-004 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 2f5b1b0b-fd8a-4c4e-a85a-519ca841a0db | 2026-05-19 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Upsher-Smith Laboratories, LLC | 691d276c-9cc1-4d39-828f-0f44d7ef6328 | 2026-05-15 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Vitruvias Therapeutics, Inc. | a9d7c5ef-daf9-4f97-8673-7f4a2007f408 | 2026-05-07 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 54bfabce-1f8a-40ee-8b55-efce8fe6fbf1 | 2026-04-30 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 149d20de-f262-4567-aa97-d4d28a1653cb | 2026-04-30 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Coupler LLC | 50b10a3d-883c-8891-e063-6394a90a86a1 | 2026-04-30 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 872927eb-0b61-44bb-9892-3c700b6f2181 | 2026-04-29 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Quallent Pharmaceuticals Health LLC | 9dae6824-6913-42de-b98a-cdcb0d3b4a46 | 2026-04-25 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | e4886adf-199d-4b19-a4ef-75f8f94cb54e | 2026-04-22 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Ajanta Pharma USA Inc. | b94629e3-ae2e-473e-b2f5-06e32ee19aa9 | 2026-04-20 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | a5ca2fce-bd2d-40db-b963-e3ec27c8bf23 | 2026-04-16 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | 67dcdd6e-48bc-418e-a887-805929d83ce0 | 2026-04-15 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Glenmark Pharmaceuticals Inc., USA | 35312f49-decf-428d-bf5f-4215b762ed3c | 2026-04-10 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| topiramate | TOPIRAMATE | Unichem Pharmaceuticals (USA), Inc. | 6ee00e82-799d-445e-b658-a9712c49a28e | 2026-04-06 | Warnings, Adverse reactions | topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Advagen Pharma Ltd | 48169bbc-4fb2-4bc4-9bdd-de71bf7722df | 2026-04-03 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Teva Pharmaceuticals, Inc. | 4f20155f-05b9-40ec-af34-3b58aa8d60d4 | 2026-04-01 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Zydus Pharmaceuticals USA Inc. | f72774dd-c7eb-41f9-9837-02baf77cc523 | 2026-03-30 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Lupin Pharmaceuticals, Inc. | e310afcd-1260-434e-a994-34549c789d99 | 2026-03-30 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| Topiramate | TOPIRAMATE | Aurobindo Pharma Limited | 32b48ea0-a215-43b8-83b4-a5435a686d68 | 2026-03-24 | Warnings, Adverse reactions | Topiramate TOPIRAMATE |
| TOPIRAMATE | TOPIRAMATE | Aurobindo Pharma Limited | d1588c37-9da9-4ccb-b78a-64234938a115 | 2026-03-24 | Warnings, Adverse reactions | TOPIRAMATE TOPIRAMATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 13668-031 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-031 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-031 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-031 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-032 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-032 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-032 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-032 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-033 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-033 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-033 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-033 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-034 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-034 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-034 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 13668-034 | TOPIRAMATE | topiramate | Torrent Pharmaceuticals Limited | ANDA | Current |
| 43063-094 | TOPIRAMATE | topiramate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-094 | TOPIRAMATE | topiramate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-538 | TOPIRAMATE | topiramate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 43063-538 | TOPIRAMATE | topiramate | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |
| 52959-441 | TOPIRAMATE | topiramate | H.J. Harkins Company, Inc. | ANDA | Current |
| 52959-994 | TOPIRAMATE | topiramate | H.J. Harkins Company, Inc. | ANDA | Current |
| 61919-185 | TOPIRAMATE | topiramate tablet | DIRECT RX | ANDA | Current |
| 61919-825 | TOPIRAMATE | TOPIRAMATE | DIRECT RX | ANDA | Current |
| 61919-825 | TOPIRAMATE | TOPIRAMATE | DIRECT RX | ANDA | Current |
| 68788-9730 | TOPIRAMATE | topiramate | Preferred Pharmaceuticals | ANDA | Current |